Difference between revisions of "Aop:177"

From AOP-Wiki
Jump to: navigation, search
 
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
{{#widget:Revisions}}
+
= Status =
{{#widget:Network}}
+
<span style="color:#FF0000">
 +
This is a legacy representation of this AOP. Please see the current version here:
 +
 
 +
[//{{SERVERNAME}}/aops/177 https://{{SERVERNAME}}/aops/177]
 +
</span>
 +
 
 +
 
 
== AOP Title ==  
 
== AOP Title ==  
 
<div id='longTitle' class='Title'> Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality </div>
 
<div id='longTitle' class='Title'> Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality </div>

Latest revision as of 23:46, 11 December 2016

Status

This is a legacy representation of this AOP. Please see the current version here:

https://aopwiki.org/aops/177


AOP Title

Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
Short name: Cox1 inhibition renal failure

Authors

Kellie Fay

Status

Please follow the link to snapshots page to view and create Snapshots of this AOP.

Under development: Do not distribute or cite.

This AOP page was last modified on 12/11/2016.

Click here to show/hide revision dates for related pages

Page Revision Date/Time


Abstract

Background (optional)

Summary of the AOP

Please follow link to widget page to edit this section.

If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.

Molecular Initiating Event

Molecular Initiating Event Support for Essentiality
Cyclooxygenase 1 activity, Inhibition Moderate

Key Events

Event Support for Essentiality
Prostaglandin F2alpha concentration, plasma , Decreased
renal ischemia, Occurrence
renal proximal tubular necrosis, Occurrence
blood potassium concentration, Increased
cardiac arrhythmia, Occurrence
Oxidative Stress, Increased
blood uric acid concentration, Increased
tophi (urate) deposition, Occurrence

Adverse Outcome

Adverse Outcome
Mortality, Increased
Population, Decline

Relationships Among Key Events and the Adverse Outcome

Event Description Triggers Weight of Evidence Quantitative Understanding
Prostaglandin F2alpha concentration, plasma , Decreased Indirectly Leads to renal ischemia, Occurrence Weak
renal proximal tubular necrosis, Occurrence Directly Leads to blood potassium concentration, Increased Strong
Cyclooxygenase 1 activity, Inhibition Directly Leads to Prostaglandin F2alpha concentration, plasma , Decreased
blood potassium concentration, Increased Directly Leads to cardiac arrhythmia, Occurrence
cardiac arrhythmia, Occurrence Directly Leads to Mortality, Increased
renal ischemia, Occurrence Indirectly Leads to Oxidative Stress, Increased
Oxidative Stress, Increased Indirectly Leads to renal proximal tubular necrosis, Occurrence
renal proximal tubular necrosis, Occurrence Directly Leads to blood uric acid concentration, Increased Strong
blood uric acid concentration, Increased Directly Leads to tophi (urate) deposition, Occurrence Strong
tophi (urate) deposition, Occurrence Indirectly Leads to renal proximal tubular necrosis, Occurrence
blood uric acid concentration, Increased Indirectly Leads to Oxidative Stress, Increased

Network View

   Cytoscape Web will replace the contents of this div with your graph.

Click nodes or edges.

Life Stage Applicability

Life Stage Evidence Links
Adult Strong

Taxonomic Applicability

Name Scientific Name Evidence Links
Gyps coprotheres Gyps coprotheres Strong NCBI
Gyps rueppelli Gyps rueppellii Moderate NCBI
Gyps fulvus Gyps fulvus Strong NCBI
Gyps himalayensis Moderate NCBI
Gyps bengalensis Gyps bengalensis Strong NCBI
Gyps africanus Gyps africanus Strong NCBI
Gyps indicus Gyps indicus Strong NCBI
Gallus gallus Gallus gallus Strong NCBI
Aegypius monachus Aegypius monachus Moderate NCBI

Sex Applicability

Sex Evidence Links
Male Strong
Female Strong

Graphical Representation

Click to upload graphical representation

Overall Assessment of the AOP

Domain of Applicability

Life Stage Applicability, Taxonomic Applicability, Sex Applicability
Elaborate on the domains of applicability listed in the summary section above. Specifically, provide the literature supporting, or excluding, certain domains.

Essentiality of the Key Events

Molecular Initiating Event Summary, Key Event Summary
Provide an overall assessment of the essentiality for the key events in the AOP. Support calls for individual key events can be included in the molecular initiating event, key event, and adverse outcome tables above.

Weight of Evidence Summary

Summary Table
Provide an overall summary of the weight of evidence based on the evaluations of the individual linkages from the Key Event Relationship pages.

Quantitative Considerations

Summary Table
Provide an overall discussion of the quantitative information available for this AOP. Support calls for the individual relationships can be included in the Key Event Relationship table above.

Considerations for Potential Applications of the AOP (optional)

References